Engaging Patients in Colon Cancer Screening Decisions During COVID-19
The goal of the study is to examine whether a shared decision making intervention improves decision making about colon cancer screening for patients who had their colonoscopy delayed or postponed due to the COVID pandemic. Eligible patients (n=800) will be randomly assigned to either the intervention or control arm. A subset will be surveyed about 6-8 weeks post intervention to measure shared decision making, their intention to follow through with screening, and their decisional conflict. Study staff will conduct medical chart review to track receipt of colon cancer screening within 6 months. The statistician will test whether patients in the intervention arm report more shared decision making, less decisional conflict, higher intention to follow through on screening and have higher screening rates compared to those in the control arm.
Checked against the public recordLast updated Feb 22, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Behavioral: Shared Decision Making
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adults, age 45-75 * Had screening or surveillance colonoscopy delayed or cancelled from March-June 2020 Exclusion Criteria: * Diagnostic colonoscopy * High risk for colorectal cancer as indicated by 1 year follow up schedule * Prior history of colon cancer * Unable to read or write in English or Spanish * Have already scheduled or completed a colonoscopy since restrictions were lifted
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General HospitalBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 22, 2023. Always confirm current availability with the study team.